Investing.com -- Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to ...

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the voluntary recall of intraocular lenses on its enVista platform. The recall ...

Bausch + Lomb (NYSE:BLCO) on Thursday announced a voluntary recall of several brands of intraocular lenses marketed under its enVista brand in response to reports of adverse events. Accordingly ...

Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses ...

Eye health company Bausch & Lomb is recalling some of its intraocular lenses over possible safety concerns. The voluntary recall comes after the company “received reports of complications ...

See reviews below to learn more or submit your own review. Bausch & Lomb has manufactured eye health products and vision care solutions since 1853. The company is a global supplier of contact ...

Bausch + Lomb is currently communicating with eye care professionals. Credit: ©2025 Bausch + Lomb. Bausch + Lomb has reported a “voluntary recall” of certain intraocular lenses (IOLs) on its enVista ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) ...

president of Global Pharmaceuticals and International Consumer at Bausch + Lomb, in the release. “These study results build on an impressive data set showing Miebo as a well-tolerated and effective ...